[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349269-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349269-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","associations-of-novel-adiposity-indices-with-gynecological-cancer-risk-among-adult-women-evidence-from-nhanes-2011-to-2018","Associations of novel adiposity indices with gynecological cancer risk among adult women - Evidence from NHANES 2011 to 2018","","Central adiposity is a major metabolic risk factor, yet its links to gynecological cancers remain incompletely clarified. This observational analysis evaluated associations of Body Roundness Index (BRI) and A Body Shape Index (ABSI) with gynecologic cancer status in 8116 U.S. women aged 20 years and older using NHANES 2011–2018. After adjusting via multivariable logistic regression, higher BRI and ABSI independently corresponded to increased cancer odds, strongest in overweight women and non-users of female hormones.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/associations-of-novel-adiposity-indices-with-gynecological-cancer-risk-among-adult-women-evidence-from-nhanes-2011-to-2018/349269/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/associations-of-novel-adiposity-indices-with-gynecological-cancer-risk-among-adult-women-evidence-from-nhanes-2011-to-2018/349269.png","ImageObject",300,407,{"name":42,"@type":43},"Dipper","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data source and population were used to study BRI and ABSI?","Question",{"text":63,"@type":64},"The study analyzed 8116 U.S. women aged 20 years and older from NHANES 2011–2018. Gynecologic cancer status was based on self-reported physician diagnosis of cervical, endometrial, or ovarian cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were BRI and ABSI defined in the study?",{"text":68,"@type":64},"BRI and ABSI were calculated from standardized anthropometric measurements. BRI used waist circumference and height to estimate body roundness and visceral fat content, while ABSI combined waist circumference, height, and weight to reflect abdominal fat distribution.",{"name":70,"@type":61,"acceptedAnswer":71},"What was the main association between BRI/ABSI and gynecological cancer risk?",{"text":72,"@type":64},"Women with gynecological cancer had significantly higher mean BRI and ABSI than non-cases. A one-unit increase in BRI was associated with higher odds of gynecologic cancer, and women in the highest BRI and ABSI quartiles showed greater cancer odds compared with the lowest groups.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349269,1790471561,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":102,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","®  \n Observational Study   \nAssociations of novel adiposity indices with gynecological cancer risk among adult women Evidence from NHANES 2011 to 2018  \nWenhua Huang, MDa ,* , Xiao Jin, MDa  \n\n| Abstract\u003Cbr>Central adiposity is a major metabolic risk factor, but its relationship with gynecological cancers (GCs) remains incompletely understood. This study investigated the associations of Body Roundness Index (BRI) and A Body Shape Index (ABSI) with gynecological cancers among U.S. women. Data from 8116 women aged ≥ 20 years in the National Health and Nutrition Examination Survey 2011 to 2018 were analyzed. BRI and ABSI were derived from standardized anthropometric measurements. GC status was based on self-reported physician diagnosis of cervical, endometrial, or ovarian cancer. Multivariable logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for covariates. Women with GC (n = 194) had significantly higher mean BRI and ABSI values than non-GC participants. Each one-unit increase in BRI was associated with a 14% higher odds of GC (OR = 1. 14, 95% CI: 1.03–1.31, P = .019) . Compared to the lowest quartile, women in the highest BRI quartile had 1.71-fold greater odds of GC (95% CI: 1.11–2.62) . For ABSI, women in the top quartile had 1.53-fold higher odds (95% CI: 1.01–2.32) . Associations were strongest among overweight women and those not using female hormones. Higher BRI and ABSI, reflecting central adiposity, were independently associated with increased odds of gynecological cancer in U.S. women. These indices may serve as practical markers for identifying women at elevated cancer risk. |\n| --- |\n| Abbreviations: ABSI = A Body Shape Index, BMI = body mass index, BRI = Body Roundness Index, CI = confidence interval , GC = gynecological cancer, NHANES = National Health and Nutrition Examination Survey, OR = odds ratio, PIR = poverty income ratio, WC = waist circumference. |\n| Keywords: anthropometry, body composition, gynecologic neoplasms, NHANES, obesity |\n\n1. Introduction  \nGynecological cancers (GCs) including cervical, endometrial (uterine), and ovarian malignancies, remain significant global health concerns for women. In 2022, roughly 1.47 million new cases and 680,000 deaths from gynecologic cancers were reported worldwide. [1] Excess adiposity is a known risk factor in this context, especially for endometrial cancer.[2] Adiposity also appears to influence ovarian cancer development, and although cervical cancer is driven chiefly by human papillomavirus, metabolic factors may modulate its progression. [3,4]  \nTraditional obesity metrics like body mass index (BMI) and waist circumference (WC) have limitations. BMI cannot distinguish fat from lean mass or reflect fat distribution,[5] and WC correlates strongly with overall body size.[6] Consequently, newer anthropometric indices have been proposed to better capture body shape and central adiposity. The Body Roundness Index (BRI) and A Body Shape Index (ABSI) are 2 such measures.  \nBRI incorporates WC and height to estimate body roundness and visceral fat content,[7] while ABSI combines WC, height, and weight into an index of abdominal fat distribution. [8] Both indices correlate strongly with visceral adiposity and have been linked to cardiometabolic risk beyond traditional measures. [7,8] Emerging evidence links these novel indices to cancer risk, but data specifically on gynecologic cancers are sparse. In a clinical study of women evaluated for endometrial pathology, Wilczyński et al found that higher ABSI was significantly associated with the presence of endometrial cancer or atypical hyperplasia. [8] In breast cancer research, Farhadnejad et al reported that women in the highest tertile of BRI had over twice the odds of breast cancer compared to those in the lowest tertile,[9] whereas ABSI showed no significant association. Luo et al further observed that BRI was nonlinearly associated with  \noverall cancer incidence ","cbCaindkm10jLENO","https://ap.wps.com/l/cbCaindkm10jLENO","pdf",566412,"English","# Introduction\n## Rationale and knowledge gap\n## Limitations of traditional obesity metrics\n## Novel adiposity indices (BRI and ABSI)\n## Prior evidence in cancer research\n## Study funding, ethics, and data availability","[{\"question\":\"What data source and population were used to study BRI and ABSI?\",\"answer\":\"The study analyzed 8116 U.S. women aged 20 years and older from NHANES 2011–2018. Gynecologic cancer status was based on self-reported physician diagnosis of cervical, endometrial, or ovarian cancer.\"},{\"question\":\"How were BRI and ABSI defined in the study?\",\"answer\":\"BRI and ABSI were calculated from standardized anthropometric measurements. BRI used waist circumference and height to estimate body roundness and visceral fat content, while ABSI combined waist circumference, height, and weight to reflect abdominal fat distribution.\"},{\"question\":\"What was the main association between BRI/ABSI and gynecological cancer risk?\",\"answer\":\"Women with gynecological cancer had significantly higher mean BRI and ABSI than non-cases. A one-unit increase in BRI was associated with higher odds of gynecologic cancer, and women in the highest BRI and ABSI quartiles showed greater cancer odds compared with the lowest groups.\"}]","Associations of novel adiposity indices with gynecological cancer risk among adult women - Evidence from NHANES 2011 to 2018 | PDF",1790082527,15,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1450d22e2e6534e0b336af02872eb962.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05b64d036ca67246cd329d218ae5d3df.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33af0788aee3cf534ccdbb20a67e2328.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75720f15c50822d035db590501f235f2.webp",980,1306]